Bionano Genomics, Inc. (BNGO)

USD 4.39

(-0.34%)

Total Liabilities Summary of Bionano Genomics, Inc.

  • Bionano Genomics, Inc.'s latest annual total liabilities in 2023 was 118.24 Million USD , up 103.51% from previous year.
  • Bionano Genomics, Inc.'s latest quarterly total liabilities in 2024 Q2 was 49.02 Million USD , down -34.83% from previous quarter.
  • Bionano Genomics, Inc. reported annual total liabilities of 58.1 Million USD in 2022, up 45.33% from previous year.
  • Bionano Genomics, Inc. reported annual total liabilities of 39.98 Million USD in 2021, up 57.61% from previous year.
  • Bionano Genomics, Inc. reported quarterly total liabilities of 75.22 Million USD for 2024 Q1, down -36.38% from previous quarter.
  • Bionano Genomics, Inc. reported quarterly total liabilities of 62.9 Million USD for 2023 Q3, up 11.09% from previous quarter.

Annual Total Liabilities Chart of Bionano Genomics, Inc. (2023 - 2016)

Historical Annual Total Liabilities of Bionano Genomics, Inc. (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 118.24 Million USD 103.51%
2022 58.1 Million USD 45.33%
2021 39.98 Million USD 57.61%
2020 25.36 Million USD -4.78%
2019 26.63 Million USD 81.66%
2018 14.66 Million USD -75.71%
2017 60.37 Million USD 43.58%
2016 42.04 Million USD 0.0%

Peer Total Liabilities Comparison of Bionano Genomics, Inc.

Name Total Liabilities Total Liabilities Difference
OpGen, Inc. 13.44 Million USD -779.562%
Standard BioTools Inc. 159.86 Million USD 26.033%
Aspira Women's Health Inc. 8.62 Million USD -1270.662%
bioAffinity Technologies, Inc. 3.36 Million USD -3412.673%
Castle Biosciences, Inc. 86.54 Million USD -36.635%
Exact Sciences Corporation 3.32 Billion USD 96.445%
IDEXX Laboratories, Inc. 1.77 Billion USD 93.34%
Intelligent Bio Solutions Inc. 5.59 Million USD -2013.187%
iSpecimen Inc. 6.07 Million USD -1845.473%
Inotiv, Inc. 588.04 Million USD 79.891%
Psychemedics Corporation 6.59 Million USD -1692.164%
RadNet, Inc. 2.07 Billion USD 94.297%
Prenetics Global Limited 44.01 Million USD -168.662%
Neuronetics, Inc. 81.64 Million USD -44.838%
Star Equity Holdings, Inc. 21.67 Million USD -445.546%
Exagen Inc. 34.25 Million USD -245.247%
CareDx, Inc 223.28 Million USD 47.043%
Check-Cap Ltd. 1.33 Million USD -8790.752%
Twist Bioscience Corporation 152.97 Million USD 22.7%
Guardant Health, Inc. 1.62 Billion USD 92.735%
Biodesix, Inc. 94.51 Million USD -25.108%
BioNexus Gene Lab Corp. 1.74 Million USD -6688.232%
Precipio, Inc. 3.67 Million USD -3120.234%
Natera, Inc. 691.79 Million USD 82.907%
Fulgent Genetics, Inc. 139.82 Million USD 15.431%
Sera Prognostics, Inc. 25.28 Million USD -367.694%
23andMe Holding Co. 206.64 Million USD 42.778%
OPKO Health, Inc. 622.47 Million USD 81.004%
Personalis, Inc. 95.65 Million USD -23.614%
Aclaris Therapeutics, Inc. 40.22 Million USD -193.957%
Applied DNA Sciences, Inc. 8.77 Million USD -1246.905%
T2 Biosystems, Inc. 62.83 Million USD -88.193%
Neogen Corporation 1.44 Billion USD 91.789%
Myriad Genetics, Inc. 312.9 Million USD 62.209%
ICON Public Limited Company 7.74 Billion USD 98.474%
NeoGenomics, Inc. 739.69 Million USD 84.014%
Star Equity Holdings, Inc. 21.67 Million USD -445.546%
MDxHealth SA 121.92 Million USD 3.016%
Prenetics Global Limited 44.01 Million USD -168.662%
Illumina, Inc. 4.36 Billion USD 97.292%
DarioHealth Corp. 38.24 Million USD -209.183%
ENDRA Life Sciences Inc. 1.09 Million USD -10697.265%
Medpace Holdings, Inc. 1.09 Billion USD 89.229%
Mainz Biomed B.V. 12.15 Million USD -872.442%
Trinity Biotech plc 83.38 Million USD -41.81%
Sotera Health Company 2.68 Billion USD 95.599%
bioAffinity Technologies, Inc. 3.36 Million USD -3412.673%